# Gene-Specific Analysis of Treatment vs Control Data

## Overall Statistics

Total variants: 44
Variants in genes: 0 (0.0%)
Variants in ergosterol pathway genes: 0 (0.0%)
Variants in other genes: 0 (0.0%)
Variants in non-genic regions: 44 (100.0%)

## Variants by Treatment and Gene Status

### WTA
Total variants: 9
Variants in genes: 0 (0.0%)
Variants in ergosterol pathway genes: 0 (0.0%)
Variants in other genes: 0 (0.0%)
Variants in non-genic regions: 9 (100.0%)

### WT-37
Total variants: 8
Variants in genes: 0 (0.0%)
Variants in ergosterol pathway genes: 0 (0.0%)
Variants in other genes: 0 (0.0%)
Variants in non-genic regions: 8 (100.0%)

### STC
Total variants: 9
Variants in genes: 0 (0.0%)
Variants in ergosterol pathway genes: 0 (0.0%)
Variants in other genes: 0 (0.0%)
Variants in non-genic regions: 9 (100.0%)

### CAS
Total variants: 9
Variants in genes: 0 (0.0%)
Variants in ergosterol pathway genes: 0 (0.0%)
Variants in other genes: 0 (0.0%)
Variants in non-genic regions: 9 (100.0%)


## Purifying Selection Analysis

Evidence of purifying selection can be assessed by comparing the proportion of variants
in ergosterol pathway genes versus non-ergosterol genes and non-genic regions.